Clinical-Grade Devices

Before diabetes arrives, there is a window. The CDC estimates 96 million American adults have pre-diabetes, and most of them do not know it. A digital program with more clinical…

Managing diabetes has always required more than a glucose number. The challenge is integrating blood sugar data with the behavioral, nutritional, and emotional factors that determine long-term outcomes. A 2023…

When a home sleep test needs to measure what polysomnography measures, the Nox T3 bridges the gap between laboratory precision and home convenience. The debate over how much diagnostic data…

An estimated 80% of moderate to severe obstructive sleep apnea cases remain undiagnosed. A wrist-worn device that requires no nasal cannula is changing the diagnostic calculus. Sleep apnea is one…

Every night, roughly 70 million Americans struggle with a sleep disorder, yet the diagnostic gold standard for unraveling what happens in their brains after lights out has remained fundamentally the…

For three decades, one wrist-worn device has defined how researchers measure sleep, light exposure, and circadian rhythms in clinical studies worldwide. A 2022 meta-analysis published in Sleep Medicine Reviews by…

The company that wrote the book on pulse oximetry accuracy brings hospital-grade oxygen monitoring to a wrist-worn form factor for the first time. In the early months of the COVID-19…

The first FDA-cleared cuffless blood pressure monitor designed for hospital and remote patient monitoring brings continuous hemodynamic surveillance to patients who need it most. Blood pressure is measured billions of…

When a two-week cardiac monitor is not enough, the BioTelemetry MCOT Patch extends the diagnostic window to 30 continuous days of real-time ECG surveillance. In 2019, a landmark study published…

Atrial fibrillation is the most common cardiac arrhythmia, affecting an estimated 6 million Americans, but its intermittent nature means that traditional 24 to 48 hour Holter monitors miss the majority…